These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease. Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242 [TBL] [Abstract][Full Text] [Related]
4. Natural Molecules From Chinese Herbs Protecting Against Parkinson's Disease via Anti-oxidative Stress. Ding Y; Xin C; Zhang CW; Lim KL; Zhang H; Fu Z; Li L; Huang W Front Aging Neurosci; 2018; 10():246. PubMed ID: 30233351 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease. Cai H; Liu G; Sun L; Ding J Transl Neurodegener; 2014; 3():27. PubMed ID: 25705376 [TBL] [Abstract][Full Text] [Related]
6. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
7. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052 [TBL] [Abstract][Full Text] [Related]
8. Glutathione Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M Front Neurol; 2018; 9():222. PubMed ID: 29681884 [TBL] [Abstract][Full Text] [Related]
10. A secret that underlies Parkinson's disease: The damaging cycle. Sun F; Deng Y; Han X; Liu Q; Zhang P; Manzoor R; Ma H Neurochem Int; 2019 Oct; 129():104484. PubMed ID: 31173779 [TBL] [Abstract][Full Text] [Related]
11. A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress. Li S; Liu Y; Lu S; Xu J; Liu X; Yang D; Yang Y; Hou L; Li N Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38625515 [TBL] [Abstract][Full Text] [Related]
12. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Heman-Ackah SM; Hallegger M; Rao MS; Wood MJ Front Mol Neurosci; 2013 Nov; 6():40. PubMed ID: 24312000 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins. Kanagaraj N; Beiping H; Dheen ST; Tay SS Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712 [TBL] [Abstract][Full Text] [Related]
14. The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease. Ren H; Zhai W; Lu X; Wang G Front Aging Neurosci; 2021; 13():691881. PubMed ID: 34168552 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716 [TBL] [Abstract][Full Text] [Related]
16. GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. Cheslow L; Byrne M; Kopenhaver JS; Iacovitti L; Smeyne RJ; Snook AE; Waldman SA Res Sq; 2023 Oct; ():. PubMed ID: 37886524 [TBL] [Abstract][Full Text] [Related]
17. Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson's disease. Wimalasena K; Adetuyi O; Eldani M Front Aging Neurosci; 2024; 16():1339295. PubMed ID: 38450382 [TBL] [Abstract][Full Text] [Related]